| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 26 |
| 1 | DIAZOXIDE | 22 |
| 2 | OCTREOTIDE ACETATE | 22 |
| 3 | EVEROLIMUS TABLETS | 21 |
| 4 | METFORMIN | 18 |
| 5 | INSULIN LISPRO | 14 |
| 6 | INSULIN HUMAN | 11 |
| 7 | OCTREOTIDE | 11 |
| 8 | METFORMIN HYDROCHLORIDE | 10 |
| 9 | METFORMIN ER 500 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIAZOXIDE | 22 | 0.0299 |
| 1 | STREPTOZOCIN | 1 | 0.0043 |
| 2 | PASIREOTIDE | 7 | 0.0031 |
| 3 | LUTETIUM LU 177 DOTATATE | 8 | 0.0014 |
| 4 | EVEROLIMUS TABLETS | 21 | 0.0012 |
| 5 | MIGLITOL | 1 | 0.0010 |
| 6 | GLUCAGON | 4 | 0.0009 |
| 7 | OCTREOTIDE ACETATE | 22 | 0.0007 |
| 8 | SATRALIZUMAB | 1 | 0.0006 |
| 9 | EVEROLIMUS | 26 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 26 |
| 1 | mTOR Inhibitor Immunosuppressant [EPC] | 26 |
| 2 | Corticosteroid [EPC] | 24 |
| 3 | Insulin Analog [EPC] | 19 |
| 4 | Somatostatin Analog [EPC] | 13 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 6 | GLP-1 Receptor Agonist [EPC] | 11 |
| 7 | Insulin [EPC] | 11 |
| 8 | Proton Pump Inhibitor [EPC] | 10 |
| 9 | Platinum-based Drug [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 13 | 0.0019 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 5 | 0.0014 |
| 2 | Antihypoglycemic Agent [EPC] | 4 | 0.0009 |
| 3 | Insulin [EPC] | 11 | 0.0002 |
| 4 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Androgen [EPC] | 2 | 0.0001 |